Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide

Even with high-dose post-transplant cyclophosphamide (PT-Cy) which was initially introduced for graft-versus-host disease (GvHD) prevention in the setting of HLA-haploidentical transplantation, both acute and chronic GvHDs remain a major clinical challenge. Despite improvements in the understanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Lia, Giuseppe, Di Vito, Clara, Bruno, Stefania, Tapparo, Marta, Brunello, Lucia, Santoro, Armando, Mariotti, Jacopo, Bramanti, Stefania, Zaghi, Elisa, Calvi, Michela, Comba, Lorenzo, Fascì, Martina, Giaccone, Luisa, Camussi, Giovanni, Boyle, Eileen M., Castagna, Luca, Evangelista, Andrea, Mavilio, Domenico, Bruno, Benedetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821147/
https://www.ncbi.nlm.nih.gov/pubmed/35145514
http://dx.doi.org/10.3389/fimmu.2021.816231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821147/
https://www.ncbi.nlm.nih.gov/pubmed/35145514
http://dx.doi.org/10.3389/fimmu.2021.816231

Ejemplares similares